Vandana Singh, Author at Spark Newswire

1 minute read

Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform

Yesterday, 2:16 PM

Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.

IKNA

1 minute read

Why Is Seagen Stock Trading Higher Today?

By Vandana Singh

Yesterday, 11:05 AM

Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC:

ALPMF

1 minute read

Walgreens in the Crosshairs: FDA Warnings Lead to Consumer Lawsuit Over Risky Eye Drops

By Vandana Singh

Yesterday, 10:28 AM

Walgreens Boots Alliance Inc (NASDAQ: WBA) is in hot water as it grapples with a proposed class action lawsuit in Florida federal court alleging that the pharmacy retailer mislabeled eyedrops designed to treat pink eye (conjunctivitis), misleading consumers into believing the product was safe and effect

WBA

2 minute read

Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer

By Vandana Singh

Yesterday, 10:21 AM

Merck & Co Inc (NYSE: MRK) and Eisai Co Ltd (OTC: ESALY) (OTC:

ESALF

1 minute read

Bristol Myers’ Lead Cancer Drug Opdivo Regime Meets Primary Goal In Phase 3 Lung Cancer Study

By Vandana Singh

Yesterday, 10:18 AM

Bristol Myers Squibb & Co (NYSE: BMY) announced interim data from Phase 3 CheckMate -77T trial evaluating the perioperative regimen of neoadjuvant (before surgery) Opdivo (nivolumab) with chemotherapy followed by surgery and

BMY

1 minute read

30 US States Pause Medicaid Disenrollment Due To Technical Glitch

By Vandana Singh

Yesterday, 7:56 AM

The U.S.

EVH

1 minute read

California Attorney General Cracks Down On Deceptive Abortion Pill Reversal Claims

By Vandana Singh

Yesterday, 7:54 AM

California Attorney General Rob Bonta has taken legal action against two anti-abortion organizations, Heartbeat International (HBI) and RealOptions Obria, for making unsupported claims about reversing the effects of the

BIIB

1 minute read

From Years to Months: How AI is Shaping the Landscape of Clinical Trials

By Vandana Singh

Yesterday, 7:49 AM

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These human studies, crucial to drug development, can take years and accrue costs in the billions.

AMGN

1 minute read

Better Than Chemotherapy – AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting

By Vandana Singh

Yesterday, 7:46 AM

AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo (OTC: DSKYF) (OTC:

AZN

1 minute read

Investors Eye CymaBay’s AFFIRM Study As Regulatory Uncertainties Ease

By Vandana Singh

September 21, 4:06 PM

Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar on clinical outcomes in patients with compensated cirrhosis due to

CBAY